Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

78 results about "Catenin Proteins" patented technology

Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells. The first two catenins that were identified became known as α-catenin and β-catenin. A-catenin can bind to β-catenin and can also bind actin.

Anti-hair loss and hair growth peptide with alternately arranged D / L amino acids as well as preparation method and application of anti-hair loss and hair growth peptide

ActiveCN120554457ACosmetic preparationsHair cosmeticsRink amide resinCatenin Proteins
The invention relates to an anti-hair loss and hair growth peptide with alternately arranged D / L amino acids as well as a preparation method and application of the anti-hair loss and hair growth peptide, and belongs to the technical field of biological medicines. The amino acid sequence of the polypeptide is shown as SEQ ID NO: 1, D-type and L-type amino acids are alternately arranged and designed, the protease degradation resistance is remarkably enhanced, the in-vitro half-life period is larger than or equal to 48 hours, and beta-catenin protein expression in hair follicle stem cells is activated. The preparation method comprises the following steps: taking Rink Amide resin as a carrier, sequentially coupling D / L type amino acid by adopting an Fmoc solid-phase synthesis method, cracking the resin by trifluoroacetic acid, and purifying by high performance liquid chromatography, so that the yield is more than or equal to 80%, the purity is more than or equal to 96%, and the molecular weight is confirmed to be 956.12 Da by mass spectrometry. The polypeptide can be applied to preparation of anti-hair loss and hair growth cosmetics, medicines and medical instruments, and effectively solves the problems of low stability and insufficient targeting of the polypeptide in the prior art. # imgabs0 #
Owner:DO YOU KNOW MEILI BIOTECHNOLOGY (SICHUAN) CO LTD

Peptide with activity of promoting hair growth and inhibiting hair loss and application thereof

The present invention relates to a peptide having an activity of promoting hair growth or preventing or inhibiting hair loss. The peptides of the present invention have the activity of promoting the proliferation of hair follicle dermal papilla cells (HFDPC), activating cell proliferation-related signaling proteins in human dermal papilla cells, activating beta-catenin, improving the expression level of beta-catenin downstream factors, down-regulating the expression level of alopecia protein DKK-1, and increasing the expression of keratin in hair outer root sheath cells (HORSC).
Owner:CAREGEN

Use of beta-catenin as a biomarker for treating cancers using anti-Dkk-1 antibody

A method of treating a cancer in a subject in need thereof is disclosed. The cancer can be an esophageal cancer, a uterine cancer, a liver cancer, or a cholangiocarcinoma. The method comprises administering to the subject an effective amount of an anti-Dkk-1 antibody or antigen binding-fragment thereof, wherein the subject is determined to have a constitutively activating mutation of the beta-catenin protein.
Owner:LEAP THERAPEUTICS INC

Application of mesenchymal stem cell-derived exosome in preparation of medicine for preventing and treating hyperxia-induced type II alveolar epithelial cell injury

The invention discloses application of a mesenchymal stem cell-derived exosome in preparation of a medicine for preventing and treating hyperxia-induced II-type alveolar epithelial cell injury, and belongs to the technical field of biological medicines. The protective effect and potential mechanism of the mesenchymal stem cell-derived exosome on ferroptosis and autophagy in high-oxygen-induced type II alveolar epithelial cell injury are discussed through experiments, and the mesenchymal stem cell-derived exosome reduces ROS accumulation of the high-oxygen-induced type II alveolar epithelial cells by promoting proliferation of the type II alveolar epithelial cells, so that the growth of the high-oxygen-induced type II alveolar epithelial cells is promoted, and the growth of the high-oxygen-induced type II alveolar epithelial cells is promoted. According to the present invention, the expression of GPX4 and SLC7A11 in the high-oxygen-induced type II alveolar epithelial cells is increased, the expression quantities of Wnt 1, beta-catenin and p62 are increased, and the expression quantities of ATG5 and Beclin1 are reduced, such that the effect of preventing and treating the high-oxygen-induced type II alveolar epithelial cell injury is achieved, and the theoretical basis is provided for the clinical application of the mesenchymal stem cell-derived exosome.
Owner:遵义医科大学第二附属医院

Pharmaceutical composition for treating osteosarcoma and application thereof

The invention discloses a pharmaceutical composition for treating osteosarcoma and application of the pharmaceutical composition, and particularly belongs to the field of biological medicine. The pharmaceutical composition comprises cis-platinum and daidzin, the daidzin provided by the invention is combined with beta-catenin protein, so that the protein stability of the beta-catenin protein is reduced, and a Wnt signal channel is further inhibited, so that the activity of osteosarcoma cells is inhibited, cell apoptosis is induced, and pulmonary metastasis is inhibited; the pharmaceutical composition of cis-platinum and daidzin provided by the invention has a synergistic effect, the sensitivity of cells to cis-platinum is remarkably improved, and the daidzin and cis-platinum combined medication has a remarkable inhibition effect on the activity and migration invasion ability of osteosarcoma cells.
Owner:THE THIRD AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIVERSITY (GUANGZHOU SEVERE MATERNAL TREATMENT CENTER GUANGZHOU ROUJI HOSPITAL)

A mellea extract for treating ulcerative colitis, and its preparation method and application

The present invention provides a kind of radix schizonepetae extract for treating ulcerative colitis and its preparation method and application, and relates to the field of biomedicine technology. The preparation method of the radix schizonepetae extract of the present invention comprises: soaking radix schizonepetae in water, heating and boiling, condensing and refluxing, filtering, and collecting the filtrate, which is the radix schizonepetae extract. The radix schizonepetae extract of the present invention can reduce collagen deposition and intestinal epithelial cell apoptosis in the colon epithelium of ulcerative colitis, has the effect of downregulating the abnormally high expression of genes and proteins such as N-cadherin, IntegrinA1, Vinculin, TGF-β2, Srcin, etc. in the colon tissue of ulcerative colitis, reduces colon fibrosis and inflammatory damage, protects the barrier function of the colon epithelium, and has the effect of inhibiting the overexpression of Wnt 5A / B and β-Catenin proteins caused by DSS, and alleviates colon fibrosis, thereby achieving the effect of treating ulcerative colitis and alleviating colon fibrosis.
Owner:ZHEJIANG CHINESE MEDICAL UNIVERSITY

Cosmetic use of a composition for improving white hair

PendingCN122320809AGraying hairsMelanin synthesis
This invention relates to the cosmetic use of a composition for improving gray hair. The composition of this invention promotes melanin synthesis in hair by activating the Wnt / β-catenin signaling pathway, thereby exhibiting significant and excellent effects in inhibiting, preventing, improving, alleviating, delaying, or treating gray hair (white hair syndrome).
Owner:LG HOUSEHOLD & HEALTH CARE LTD

Peptides having activity to promote hair growth and inhibit hair loss and uses thereof

The present invention relates to a peptide having an activity of promoting hair growth or preventing or inhibiting hair loss. The peptide of the present invention has an activity of promoting proliferation of hair follicle dermal papilla cells (HFDPC), activating a cell proliferation-related signal protein in human dermal papilla cells, activating β-catenin, improving expression levels of factors downstream of β-catenin, down-regulating expression levels of hair-loss protein DKK-1, and increasing expression of keratins in hair outer root sheath cells (HORSC).
Owner:CAREGEN

Beta-catenin-binding peptides and peptidomimetics and uses thereof

The invention relates to β-catenin-binding peptides and peptidomimetics comprising an amino acid sequence ESILDEHXQRVW or EYPESILDEHXQRVWR, wherein X is L, M, I, F, Y, W or C, or a variant of said amino acid sequences, and to uses thereof.
Owner:STICHTING VU

Hair follicle regeneration nano activator as well as preparation method and application thereof

The invention relates to the technical field of biological medicines, and particularly provides a hair follicle regeneration nano activator as well as a preparation method and application thereof. The activator comprises a first coupling monomer and a second coupling monomer, an oligonucleotide sequence of the first coupling monomer and an oligonucleotide sequence of the second coupling monomer are at least partially complementary and form a double-chain structure through base pairing, the first coupling monomer is formed by coupling a first polypeptide and a first ssDNA, and the second coupling monomer is formed by coupling a second polypeptide and a second ssDNA. The second coupling monomer is formed by coupling a second polypeptide and a second ssDNA; wherein the first polypeptide and the second polypeptide are both specifically targeted to beta-catenin protein. The polypeptide-DNA-polypeptide dimer has a polypeptide-DNA-polypeptide sandwich-type dimer structure, can be specifically combined with beta-catenin in stem cells, only regulates and controls a Wnt / beta-catenin pathway, does not generate non-specific influence on other pathways, and can efficiently activate a hair follicle regeneration related signal pathway and promote a hair follicle development biological process.
Owner:HUNAN UNIV

Multivalent FZD4, WNT co-receptor, and VEGF receptor molecules and uses thereof

Herein are multivalent antibody binding molecules that activate a Wnt / β-catenin signaling pathway comprising a FZD4 receptor binding domain, an LRP5 co-receptor binding domain, and a VEGF binding domain. Also described herein are nucleic acids and vectors encoding said molecules and methods for their use.
Owner:MERCK SHARP & DOHME LLC +1

Methods of inhibiting FOXO1 for treatment of lymphatic disorders

InactiveUS20250009734A1Heterocyclic compound active ingredientsCongenital lymphedemaLymphatic Disorders
Disclosed are methods for treating congenital lymphedema or increasing lymphatic valve growth by administering a FOXO1 inhibitor. Also disclosed are methods for increasing nuclear β-catenin activity in a cell by contacting the cell with a FOXO1 inhibitor.
Owner:UNIV OF SOUTH FLORIDA

Anti-beta-catenin antibodies

The present disclosure relates to antibodies against beta-catenin and formulations comprising the antibodies. The present disclosure also relates to the use of beta-catenin antibodies and formulations in therapy, in particular in the treatment of solid cancer.
Owner:UCB BIOPHARMA SPRL

Beta-catenin depot detection and modulation assays

The present application provides, in some aspects, methods of determining a beta-catenin depot and uses thereof, for example, to identify compounds that modulate, such as increase, a beta-catenin depot in a cell. Also provided herein, in other aspects, are related methods, such as methods of identifying compounds for the treatment of beta-catenin associated diseases, kits, and useful compounds identified thereby.
Owner:DEWPOINT THERAPEUTICS INC

Composition for preventing hair loss or promoting hair growth

The present invention relates to a composition for preventing hair loss or promoting hair growth, containing an ingredient for promoting hair growth or delaying hair loss. In order to confirm this, the wnt / beta-catenin signaling pathway activity promoting effect, the hair papilla cell proliferation effect, and the beta-catenin protein expression amount increasing effect wnt / beta-catenin signaling pathway activity promoting effect, the hair papilla cell proliferation effect and the beta-catenin protein expression amount increasing effect have been confirmed by in vitro experiments. Further, it is confirmed that a good result is exhibited in a researcher evaluation by clinical photograph shooting and an evaluation by hair image shooting after use, thereby exhibiting a high effect of preventing hair loss and / or hair growth. In view of these comprehensive results, the composition of the present invention has excellent effects of preventing hair loss and / or promoting hair growth.
Owner:LG HOUSEHOLD & HEALTH CARE LTD

Composition for preventing or treating cancer disease comprising aryl piperidine derivative

The present invention relates to a pharmaceutical composition comprising an aryl piperidine derivative compound or a pharmaceutically acceptable salt thereof for use in the treatment or prevention of tankyrase-related cancer diseases. The pharmaceutical composition inhibits the enzymatic activity of tankyrase (TNKS), inhibits the expression of a beta-catenin target gene and the protein expression of active beta-catenin, stabilizes AXIN2 protein levels, and exhibits anti-cancer activity in a cancer cell line, so that the compound can be used as an anti-cancer agent, in particular as an anti-cancer agent. And elicits synergistic effects in combination therapy with other anti-cancer agents.
Owner:KOREA RES INST OF CHEM TECH +1

Methods of treating cancer having an active WNT / beta-catenin pathway

The present invention provides methods of treating a subject having a Wnt / beta-catenin active cancer by administering to said subject a compound that inhibits the expression or activity of YES1, BIRC5 or BCL2L1, a compound that inhibits YAP1-beta-catenin complex formation, a compound that inhibits YAP1-beta-catenin complex binding to DNA, a compound that inhibits YAP1-beta-catenin-TBX5 complex formation, or any combination thereof. The compound can be, for example, a nucleic acid, a peptide, an antibody or a small molecule. Methods of screening for therapeutic targets for treating cancer are included.
Owner:DANA FARBER CANCER INSTITUTE INC

Composition containing synergistic quadruple peptide

The invention provides a composition containing a synergistic quadruple peptide. The quadruple peptide comprises acetyl dipeptide-1 cetyl ester, palmitoyl tripeptide-8, hexapeptide-3 and / or polytripeptide-6; the quadruple peptide achieves synergistic effects of strengthening cell adhesion, strengthening cell defense, improving moisturizing capacity and / or resisting inflammation and relieving by remarkably promoting phosphorylation of an epidermal growth factor receptor (EGFR), phosphorylation of serine / threonine kinase (Akt) and / or expression of catenin (beta-catenin). The composition containing the synergistic quadruple peptide can give full play to the biological advantages of each functional peptide. By promoting proliferation and differentiation of epidermal cells, the self-healing power of the skin barrier is improved, endogenous root improvement is achieved, the comprehensive synergistic effect of stabilizing the skin barrier, inhibiting inflammation and soothing and soothing muscles is truly achieved, and the composition can be used in cosmetics and beauty products in various forms.
Owner:CHENGDU SUNNA BIOPEPTIDE TECH CO LTD

D / l amino acid alternately arranged anti-hair loss peptide and preparation method and application thereof

The present application relates to a kind of D / L amino acid alternate arrangement anti-hair loss hair growth peptide and its preparation method and application, belong to biological medicine technical field.The amino acid sequence of the polypeptide is as shown in SEQ ID NO:1, is designed by D type and L type amino acid alternate arrangement, significantly enhance the ability of anti-protease degradation, in vitro half-life is ≥48 hours, and activate β-catenin protein expression in hair follicle stem cell.Its preparation method includes: using Rink Amide resin as carrier, using Fmoc solid-phase synthesis method sequentially coupling D / L type amino acid, after cleaving resin by trifluoroacetic acid, by high performance liquid chromatography purification, yield is ≥80%, purity is ≥96%, mass spectrum confirms molecular weight is 956.12Da.The polypeptide can be applied to the preparation of anti-hair loss hair growth cosmetics, drugs and medical devices, effectively solve the problem of low polypeptide stability, insufficient targeting in prior art.
Owner:DO YOU KNOW MEILI BIOTECHNOLOGY (SICHUAN) CO LTD

Organic compositions to treat beta-catenin-related diseases

PendingUS20250270555A1Organic active ingredientsSkeletal disorderUterine carcinomaProstate cancer
The present disclosure relates to RNAi agents useful in methods of treating Beta-Catenin-related diseases such as adenomatous polyposis of the colon, colorectal cancer, basal cell carcinoma, breast cancer, kidney cancer, Wilms tumors, medulloblastoma, ovarian cancer, adrenocortical tumors, gastric cancer, liver cancer, melanoma, pancreatic cancers, prostate cancer, renal cancer, ectopic teeth and taste papillae, skin cancer, pilomatrixoma, anaplastic thyroid carcinoma, and uterine carcinosarcoma, oligodontia, osteoporosis, ageing, degenerative diseases, bedsores, chronic wounds and impaired wound healing, and similar and related diseases, using a therapeutically effective amount of a RNAi agent to Beta-Catenin.
Owner:ARROWHEAD PHARMACEUTICALS INC

Preparation method of stem cell-derived exosome through cell stretching and application of stem cell-derived exosome

The present invention confirms that when stem cells are phase-changed into a gel (gel) state by mixing a hydrogel in a sol state composed of a polymer capable of sol-gel (gel) phase change with the stem cells, the stem cells can be cultured at a uniform high density in a 3D state. Furthermore, when the stem cells are cultured by the method, the stem cells are stretched by adjusting the hydrogel structure to transduce a physical stimulus to the cells, thereby enabling the activation of integrinin-FAK and catenin-Wnt signaling in the cells, and thus it is confirmed that the efficiency of exosome production is increased and functional components are increased. Furthermore, it is confirmed that in the exosome prepared by the method provided by the invention, miRNA components capable of regulating angiogenesis, tissue regeneration and inflammation are increased. Therefore, the exosome prepared by the method of the present invention can be effectively used as a composition for angiogenesis, tissue regeneration, or anti-inflammation.
Owner:韩创干细胞生物科技公司

Peptides that promote hair growth and inhibit hair loss and their uses

ActiveCN120019063BMedicineDermal papillae
This invention relates to peptides that promote hair growth or prevent or inhibit hair loss. The peptides of this invention promote the proliferation of follicular dermal papilla cells (HFDPC) and human pilosebaceous dermal sheath cells (HHORSC), upregulate the expression of β-catenin secondary factor in HFDPC, upregulate the expression of growth factors in HFDPC, and downregulate the expression level of Dickkopf-1 (DKK-1), a protein that causes hair loss.
Owner:CAREGEN

Substituted imidazo[l,2-a]pyrazines and pyrazino[l,2-a] pyrimidines as topical agents for dermatological applications

Provided are compounds of formula (I):or a cosmeceutically acceptable or pharmaceutically acceptable salts thereof. Additionally provided are pharmaceutical and / or cosmeceutical compositions and formulations comprising the compounds and / or the cosmeceutically acceptable or pharmaceutically acceptable salts thereof, therapeutic and / or cosmetic methods using same for modulating (e.g., inhibiting) CREB binding protein (CBP) / β-catenin mediated signaling in treating skin related diseases, conditions or disorders (e.g., dermatitis, psoriasis, scarring, alopecia, etc.) mediated by aberrant CBP / β-catenin signaling, and cosmetic methods for treating skin conditions (e.g., aging, etc.) mediated by aberrant CBP / β-catenin signaling.
Owner:GENESIS MOLECULAR TECHNOLOGIES INC

RNA aptamer conjugates and uses thereof

Pharmaceutical compositions and compounds comprising a phosphorothioated CpG oligodeoxynucleotide linked to a DNA oligonucleotide that is hybridized an RNA aptamer are useful in methods of treating cancer (such as leukemia) and methods of inhibiting DNA methyltransferase. In embodiments, the RNA aptamer binds to an intracellular target such as DNMT1, NF-kB, RUNX1, MYC, MYB, ETS, PAX5, MDM2, F0XM1, PU.l, STAT3, STATS. STAT6, FAD, ATP5B, or beta-catenin.
Owner:CITY OF HOPE

Hepatic fibrosis therapeutic regimen of cbp / catenin inhibitor

To provide a pharmaceutical composition that is effective for preventing or treating a liver disease, particularly hepatic fibrosis or cirrhosis.SOLUTION: A pharmaceutical composition for preventing and / or treating a liver disease contains 4-({(6S,9S,9aS)-1-(benzylcarbamoyl)-2,9-dimethyl-4,7-dioxo-8-[(quinoline-8-yl)methyl]octahydro-2H-pyrazino[2,1-c][1,2,4]triazine-6-yl}methyl)phenyl dihydrogenphosphate or a pharmaceutically acceptable salt thereof, in which 100 to 400 mg / m2 of 4-({(6S,9S,9aS)-1-(benzylcarbamoyl)-2,9-dimethyl-4,7-dioxo-8-[(quinoline-8-yl)methyl]octahydro-2H-pyrazino[2,1-c][1,2,4] triazine-6-yl}methyl)phenyl dihydrogenphosphate or a pharmaceutically acceptable salt thereof is intravenously administered to a human once or twice a week or for 2 to 5 hours each time, and is used such that the administration continues for 2 to 6 months.SELECTED DRAWING: None
Owner:TOKYO METROPOLITAN HEALTH & HOSPITALS CORP +1

Method for constructing and culturing hair follicle organoid, hair drug screening method using same, and hair transplantation material

The present invention relates to techniques for constructing and culturing hair follicle-like organs for use in hair drug screening methods and in the production of hair graft materials. More specifically, in the present invention, hair follicles are isolated from existing skin organoid derived from human induced pluripotent stem cells and cultured on a culture insert coated with collagen and Matrigel to observe the growth and degradation of hair follicles. Transplanting the cultured hair follicles into the skin allows new hair to grow, demonstrating the potential use of the hair follicle organoid as a hair transplant material. According to treatment of hair follicle-like organs with hair loss inducing factors, it is observed that the hair follicle length is shortened, hair papilla cell aggregates are damaged, the expression of WNT3A or beta-catenin is reduced, and the expression of DKK-1 or TGF-beta2 is increased, so that a hair loss simulation model is established. Through observation, the organ is expected to be widely applied, such as a screening method of a hair growth promoter, a hair loss prevention agent, a hair loss alleviator or a hair loss treatment agent, and a screening method of a cosmetic composition for promoting hair growth, preventing hair loss or alleviating hair loss.
Owner:KANGSTEM BIOTECH

Peptides that promote hair growth and inhibit hair loss and their uses

This invention relates to peptides with activity that promotes hair growth or prevents or inhibits hair loss. The peptides of this invention promote the proliferation of human follicular dermal papilla cells (HFDPC), activate cell proliferation-related signaling proteins and β-catenin in HFDPC, enhance the expression levels of downstream genes of β-catenin, downregulate the expression level of the hair loss protein DKK-1, increase the expression of keratin in hair follicle outer root sheath cells (HORSC), and upregulate the expression of transcription factors involved in cell activation in germinal stromal cells (GMC).
Owner:CAREGEN